GGrantIndex
Sort

326,823 grants matching clinical trial

Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor (SPEAC) for Adults with Emotional Distress

$2,112,494
Jun Ma · University Of Illinois At Chicago · R61 · FY2020 · MH

Leniolisib for immunedysregulation

$2,112,459
Gulbu Uzel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Center for Native Oral Health Research (CNOHR)

$2,112,432
Judith E.n. Albino · University Of Colorado Denver · U54 · FY2008 · DE

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

$2,112,377
Franziska Michor · Dana-Farber Cancer Inst · U54 · FY2015 · CA

The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND)

$2,112,022
Judith S Hochman · New York University School Of Medicine · R01 · FY2021 · HL

A Multicenter Randomized Controlled Trial of Surveillance versus. Endoscopic Therapy for Barretts Esophagus with Low-grade Dysplasia: The SURVENT Trial

$2,111,999
Sachin Wani · University Of Colorado Denver · U01 · FY2024 · DK

Product Development and Manufacture

$2,111,768
Robert T McNally · Geovax, Inc. · U19 · FY2011 · AI

MRI Based Presymptomatic Prediction of ASD

$2,111,607
John R Pruett · Washington University · R01 · FY2019 · MH

HIV/STD Risk Reduction For African American Couples

$2,111,550
University Of Pennsylvania · U10 · FY2003 · MH

Oral N2O Therapy in Treating Acute Vaso-Occlusive Pain in Sickle Cell Disease

$2,111,258
Edward Gomperts · Hillhurst Biopharmaceuticals, Inc. · UG3 · FY2022 · NS

Botswana-Harvard T.H. Chan School of Public Health AIDS Initiative Partnership CTU

$2,111,151
Shahin Lockman · Harvard University D/B/A Harvard School Of Public Health · UM1 · FY2025 · AI

Core-005

$2,111,061
George Alexander Mashour · University Of Michigan At Ann Arbor · UL1 · FY2017 · TR

Molecular Basis of Mitochondrial Dysfunction in Neurodegeneration

$2,111,031
Kenneth R Norman · Albany Medical College · RF1 · FY2019 · AG

Targeting Lung Cancer Vulnerabilities

$2,110,656
John D Minna · Ut Southwestern Medical Center · P50 · FY2023 · CA

Recombinant Adeno Associated Virus Vectors for Gene Transfer

$2,110,580
Robert Kotin · National Heart, Lung, And Blood Institute · ZIA · FY2013 · HL

Role of Eosinophils in Airway Inflammation and Remodeling

$2,110,341
Nizar N Jarjour · University Of Wisconsin-Madison · P01 · FY2014 · HL

Surgery Branch Cell Prep Core

$2,110,232
Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

Cell Production Core Facility

$2,110,232
Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA

#4Corners4Health: A Social Media Cancer Prevention Program for Rural Emerging Adults

$2,109,982
David B Buller · Klein Buendel, Inc. · R01 · FY2025 · CA

Specialized Program of Research Excellence (SPORE) in Leukemia

$2,109,864
Daniel C Link · Washington University · P50 · FY2024 · CA

Center for Native Oral Health Research (CNOHR)

$2,109,604
Judith E.n. Albino · University Of Colorado Denver · U54 · FY2014 · DE

Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials

$2,109,311
Terry Goldberg · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2022 · AG

NYU Melanoma SPORE

$2,109,068
Iman Osman · New York University School Of Medicine · P50 · FY2020 · CA

Meningococcal Immunization Against Gonococcal Infection Clinical Trial

$2,108,870
National Institute Of Allergy And Infectious Diseases · Y01 · FY2024 · AI

A Controlled Clinical Trial of Regadenoson in Sickle Cell Anemia

$2,108,843
David G. Nathan · Dana-Farber Cancer Inst · P50 · FY2015 · HL